Samuel Waxman Cancer Research Foundation is located in New York, NY. The organization was established in 1983. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. As of 06/2021, Samuel Waxman Cancer Research Foundation employed 4 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Samuel Waxman Cancer Research Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2021, Samuel Waxman Cancer Research Foundation generated $2.5m in total revenue. The organization has seen a slow decline revenue. Over the past 6 years, revenues have fallen by an average of (0.1%) each year. All expenses for the organization totaled $3.6m during the year ending 06/2021. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, Samuel Waxman Cancer Research Foundation has awarded 149 individual grants totaling $9,276,014. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
THE SAMUEL WAXMAN CANCER RESEARCH FOUNDATION (THE "FOUNDATION") FUNDS INNOVATIVE RESEARCH TO BRING FASTER CURES TO PATIENTS. IN ADDITION TO SUPPORTING ONGOING COLLABORATIVE RESEARCH IN SPECIFIC CANCERS, OUR SCIENTISTS ARE INVESTIGATING THE BIOLOGY OF CANCER TO FIND TREATMENTS ACROSS DISEASE TYPES. THE WORLD CLASS SCIENTISTS WHO REPRESENT OUR INSTITUTE WITHOUT WALLS SHARE INFORMATION AND RESOURCES TO SPEED THE PACE OF CANCER RESEARCH. FOUNDATION INVESTIGATORS HAVE MADE MAJOR BREAKTHROUGHS IN CANCER- FROM DISCOVERING PATHWAYS TO DELIVER DRUGS TO IDENTIFYING POTENTIAL MINIMALLY TOXIC AND NOVEL THERAPIES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE SAMUEL WAXMAN CANCER RESEARCH FOUNDATION IS AN INTERNATIONAL ORGANIZATION DEDICATED TO CURING AND PREVENTING CANCER. THE FOUNDATION IS A PIONEER IN CANCER RESEARCH FOCUSING ON UNCOVERING THE CAUSES OF CANCER AND REPROGRAMMING CANCER CELLS. WE DEDICATE OURSELVES TO DELIVERING TAILORED, MINIMALLY TOXIC TREATMENTS TO PATIENTS. OUR MISSION IS TO ERADICATE CANCER BY BRIDGING THE GAP BETWEEN LAB SCIENCE AND THE PATIENT. THROUGH OUR COLLABORATIVE GROUP OF WORLD-CLASS SCIENTISTS, THE INSTITUTE WITHOUT WALLS, INVESTIGATORS SHARE INFORMATION AND TOOLS TO SPEED THE PACE OF CANCER RESEARCH. SINCE OUR INCEPTION IN 1976, THE FOUNDATION HAS AWARDED MORE THAN $90 MILLION TO SUPPORT THE WORK OF MORE THAN 200 RESEARCHERS ACROSS THE GLOBE.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
William T Sullivan Executive Director | OfficerTrustee | 50 | $315,000 |
Samuel Waxman MD Director | OfficerTrustee | 20 | $220,000 |
Michael Nierenberg Chairman | OfficerTrustee | 5 | $0 |
Dena K Weiner Vice President | OfficerTrustee | 1 | $0 |
Thomas A Conway Treasurer | OfficerTrustee | 2 | $0 |
Jody Gorin Secretary | OfficerTrustee | 1 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $1,583,854 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $911,030 |
Noncash contributions included in lines 1a–1f | $71,927 |
Total Revenue from Contributions, Gifts, Grants & Similar | $2,494,884 |
Total Program Service Revenue | $0 |
Investment income | $15,925 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $2,510,809 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $1,715,886 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $137,500 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $535,000 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $495,569 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $0 |
Fees for services: Management | $0 |
Fees for services: Legal | $10,620 |
Fees for services: Accounting | $96,600 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $58,022 |
Advertising and promotion | $0 |
Office expenses | $43,903 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $186,477 |
Travel | $6,361 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $2,258 |
Insurance | $14,087 |
All other expenses | $7,999 |
Total functional expenses | $3,593,053 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $0 |
Savings and temporary cash investments | $2,205,049 |
Pledges and grants receivable | $2,373,304 |
Accounts receivable, net | $11,488 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $226,345 |
Net Land, buildings, and equipment | $4,836 |
Investments—publicly traded securities | $0 |
Investments—other securities | $13,653 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $4,834,675 |
Accounts payable and accrued expenses | $158,613 |
Grants payable | $525,000 |
Deferred revenue | $111,300 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $97,452 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $23,211 |
Total liabilities | $915,576 |
Net assets without donor restrictions | $1,622,802 |
Net assets with donor restrictions | $2,296,297 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $4,834,675 |
Over the last fiscal year, Samuel Waxman Cancer Research Foundation has awarded $1,715,886 in support to 22 organizations.
Grant Recipient | Amount |
---|---|
New York, NY PURPOSE: RESEARCH GRANTS | $453,386 |
New York, NY PURPOSE: RESEARCH GRANTS | $200,000 |
La Jolla, CA PURPOSE: RESEARCH GRANTS | $150,000 |
Houston, TX PURPOSE: RESEARCH GRANTS | $100,000 |
Redwood City, CA PURPOSE: RESEARCH GRANTS | $100,000 |
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO PURPOSE: RESEARCH GRANTS | $100,000 |
Over the last fiscal year, we have identified 34 grants that Samuel Waxman Cancer Research Foundation has recieved totaling $619,041.
Awarding Organization | Amount |
---|---|
Jewish Communal Fund New York, NY PURPOSE: GENERAL SUPPORT | $116,750 |
Jim Jacobs Charitable Foundation Inc Alexandria, VA PURPOSE: GENERAL USE | $75,000 |
Goldman Sachs Charitable Gift Fund New York, NY PURPOSE: MEDICAL/SCIENTIFIC RESEARCH & PROGRAMS | $72,500 |
Theodore A Rapp Foundation Darien, CT PURPOSE: SUPPORT OF ORGANIZATION | $63,300 |
Schwab Charitable Fund San Francisco, CA PURPOSE: HEALTH | $59,100 |
Gerald L Lennard Foundation Inc Wilmington, DE PURPOSE: WOMAN SCIENTIST IN BREAST CANCER RESEARCH | $50,000 |
Organization Name | Assets | Revenue |
---|---|---|
Count Me In Inc Cambridge, MA | $7,331,909 | $8,017,841 |
Lung Cancer Research Foundation New York, NY | $5,738,095 | $6,154,252 |
The Ricbac Foundation Newtonville, MA | $46,150,580 | $5,404,964 |
Samuel Waxman Cancer Research Foundation New York, NY | $4,834,675 | $2,510,809 |
Advanced Medical Research Foundation Inc Brookline, MA | $69,323,551 | $6,501,514 |
For Petes Sake Cancer Respite Foundation Plymouth Meeting, PA | $5,811,462 | $3,990,620 |
International Myeloma Society Needham, MA | $7,371,497 | $4,469,545 |
Laniado Development Fund Inc Monsey, NY | $541,683 | $1,706,128 |
American-Italian Cancer Foundation New York, NY | $5,209,552 | $1,660,961 |
Sbarro Health Research Organization Inc Philadelphia, PA | $1,818,007 | $1,444,668 |
Stachestrong Inc Vestal, NY | $447,946 | $1,183,926 |
Arms Wide Open Childhood Cancer Foundation Marlboro, NJ | $332,441 | $1,049,867 |